Srinath Mallikarjunan, CEO of Unmanned Dynamics, warns about India's rising employment and employability crisis, citing flaws in the educat...

The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...

Lucky allottees of SME IPO Trafiksol ITS Technologies saw a 135% GMP gain turn into disappointment as BSE postponed the listing due to disc...

BSE has postponed the listing of Trafiksol ITS Technologies due to unresolved queries. The company, based in Noida, was expected to have a ...

Ashwani Bhatia, Sebi Whole-Time Member, emphasized the need for a detailed approach in addressing MSMEs' financial challenges. He highlight...

The Ministry of Health and Family Welfare has banned the manufacture, sale, and distribution of 156 fixed dose combinations. These include ...

The Odisha government has approved seven projects with a total investment of Rs 80,125 crore across various sectors, including steel, green...

Branded generics also add significant value to the healthcare ecosystem. They develop and circulate patient education materials. In-patient...

"To date this situation has impacted more than 20 products with two countries of origin (India & Indonesia) and more than 15 different manu...

"We have seen a sharp rise in the sales of drugs like paracetamol, analgesics and drugs for respiratory illnesses," said Rajiv Singhal, gen...

This will be the first of its kind alliance in India's pharmaceutical industry, to collaborate for green molecule solutions to consolidate ...

Power Grid posted over six per cent rise in its consolidated net profit to Rs 3,526.23 crore for the March 2021 quarter, mainly on the back...

The Indian drug firm had initiated the legal battle in order to remove any patent hurdle in manufacturing of intravenous paracetamol soluti...

Rowlatt advised women (and men) to amplify other women's voices.

In 2017, India imported 354 Active Pharmaceutical Ingredients (APIs) from China, a 26% dip compared to 447 in 2015.

Dr. Neha Bala, Executive Physiotherapist, Ananda In The Himalayas, tells us how to beat that chronic pain.

Hyderabad-based pharma firm Granules India is close to finalising a Rs 180-200-crore deal with a Chinese pharmaceutical company.